Versigent (VGNT) Revenue & Revenue Breakdown
Versigent Revenue Highlights
Latest Revenue (Y)
$8.82B
Latest Revenue (Q)
$2.44B
Versigent Revenue by Period
Versigent Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $8.82B | 6.13% |
| 2024-12-31 | $8.31B | -5.92% |
| 2023-12-31 | $8.83B | 10.19% |
| 2022-12-31 | $8.02B | - |
Versigent generated $8.82B in revenue during NA 2025, up 6.13% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Versigent Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-06-30 | $2.44B | 10.49% |
| 2026-03-31 | $2.21B | -3.91% |
| 2025-12-31 | $2.30B | 8.18% |
| 2024-12-31 | $2.13B | - |
Versigent generated $2.44B in revenue during Q2 2026, up 10.49% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Versigent Revenue Breakdown
Versigent Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Jun 26 | Mar 26 |
|---|---|---|
| South America | $73.00M | $67.00M |
| Asia Pacific | $825.00M | $739.00M |
| EMEA | $524.00M | $509.00M |
| North America | $1.02B | $897.00M |
Latest
Versigent's latest quarterly revenue breakdown by geography, as of Jun 26: North America (41.82%), Asia Pacific (33.76%), EMEA (21.44%), and South America (2.99%).